Daniel E

Events (6)

• October 19, 2001: FDA Considers Drug Industry’s Argument that Regulation of Ads is a Violation of Companies’ Free Speech Rights 2001-10-19
• July 2002-September 3, 2002: FDA Chief Counsel Intervenes in Lawsuit on Behalf of Drug Company 2002-09-03
• February 18, 2005: Panel Votes to Allow Bextra and Vioxx to Stay on Market; Final Vote Possibly Affected by Industry Ties 2005-02-18
• August 2001: Bush Appoints Daniel E. Troy as the FDA’s chief counsel
• October 2001: FDA Chief Counsel Orders Pre-Screening of All Enforcement Letters Sent to Drug Companies
• August 2003: FDA Sides with Drug Company in False Advertising Lawsuit